FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1486098081> ?p ?o ?g. }

• W1486098081 endingPage "261" @default.
• W1486098081 startingPage "241" @default.
• W1486098081 abstract "AllergyVolume 42, Issue 4 p. 241-261 Free Access The value of specific ANA determination in rheumatology Update 1986 A. Wiik, Corresponding Author A. Wiik Laboratory of Autoimmune Serology, Department of Clinical Immunology, Statens Seruminstitut, Copenhagen, and Skodsborg Sanitarium, Skodsborg, DenmarkAllan Wiik, M.D., Ph.D., Consultant in Rheumatology, Laboratory of Autoimmune Serology, Statens Seruminstitut, Amager Boulevard 80, DK-2300 Copenhagen, DenmarkSearch for more papers by this author A. Wiik, Corresponding Author A. Wiik Laboratory of Autoimmune Serology, Department of Clinical Immunology, Statens Seruminstitut, Copenhagen, and Skodsborg Sanitarium, Skodsborg, DenmarkAllan Wiik, M.D., Ph.D., Consultant in Rheumatology, Laboratory of Autoimmune Serology, Statens Seruminstitut, Amager Boulevard 80, DK-2300 Copenhagen, DenmarkSearch for more papers by this author First published: May 1987 https://doi.org/10.1111/j.1398-9995.1987.tb02207.xCitations: 11AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Aarden, L. A., Lakmaker, F. & De Groot, E. R.: Immunology of DNA. IV. Quantitative aspects of the Farr assay. J. Immunol. Meth. 11, 153– 163, 1976. 2 Aarden, L. A., De Groot, F. R. & Feltkamp, T. E. W.: Immunology of DNA. III Crithidia Iuciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann. N. Y. Acad. Sci. 245, 505– 515, 1975. 3 Aitcheson, C. T., Peebles, C., Joslim, F. & Tan, F. M.: Characteristics of antinuclear antibodies in rheumatoid arthritis. Reactivity of rheumatoid factors with a histone-dependent nuclear antigen. Arthritis Rheum. 23, 528– 538, 1980. 4 Akizuki, M., Powers, R. & Holman, H. R.: A soluble acidic protein of the cell nucleus which reacts with serum from patients with systemic lupus erythematosus and Søgren's syndrome. J. Clin. Invest. 59, 264– 272, 1977. 5 Alarcon-Segovia, D., Ruiz-Arguelles, A. & Llorente, L.: Antibody penetration into living cells. II. Antiribonucleoprotein IgG penetrates into Tγ lymphocytes causing their deletion and the abrogation of suppressor function. J. Immunol. 122, 1855– 18662, 1979. 6 Alarcon-Segovia, D., Llorente, L., Fishbein, E. & Diaz-Jouanen, E.: Abnormalities in the content of nucleic acids of peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Relationship to DNA antibodies. Arthritis Rheum. 23, 304– 317, 1982. 7 Alarcon-Segovia, D., Ruiz-Arguelles, A. & Fishbein, E.: Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc-receptors. Nature 271, 67– 69, 1978. 8 Alderuccio, F., Barnett, A. J., Campbell, J. H., Pedersen, J. S. & Toh, B. H.: Scl-95/100: doublet of endothelial marker autoantigens in progressive systemic sclerosis. Clin. Exp. Immunol. 64, 94– 100, 1986. 9 Alexander, E. L., Provost, T. T., Arnett, F. C. & Stevens, M. B.: Vasculitis in Sjøgren's syndrome: association with antibodies to Ro(SS-A). Abstract. Arthritis Rheum. 24, 588, 1981. 10 Alspaugh, M. A. & Maddison, P. J.: Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and Sjøgren's syndrome: An interlaboratory collaboration. Arthritisesolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and Sjøgren's syndrome: An interlaboratory collaboration. Arthritison. Arthritisn. Arthritis. Arthritisrthritis Rheum. 22, 796– 798, 1979. 11 Alspaugh, M. A., Talal, N. & Tan, E. M.: Differentiation and characterization of autoantibodies and their antigens in Sjøgren's syndrome. Arthritisifferentiation and characterization of autoantibodies and their antigens in Sjøgren's syndrome. Arthritisme. Arthritise. Arthritis. Arthritisrthritis Rheum. 19, 216– 222, 1976. 12 Alspaugh, M. A. & Tan, E. M.: Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence. Arthritis Rheum. 19, 711– 719, 1976. 13 Alspaugh, M. A. & Tan, E. M.: Antibodies to cellular antigens in Sjøgren's syndrome. J. Clin. Invest. 55, 1067– 1073, 1975. 14 Alspaugh, M. A., Rosenstock, D., Biundo, J. J. & Gupta, R. C.: Correlation of antibody to rheumatoid arthritis associated nuclear antigen and immune complexes to disease activity in patients with rheumatoid arthritis. Clin. Exp. Immunol. 51, 278– 284, 1983. 15 Alspaugh, M. A., Jensen, F. C., Rabin, H. & Tan, E. M.: Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen. J. Exp. Med. 147, 1018– 1027, 1978. 16 Beaufils, M., Kouki, F., Mignin, F., Camus, J.-P., Morel-Maroger, L. & Richet, G.: Clinical significance of anti-Sm antibodies in systemic lupus erythematosus. Am. J. Med. 74, 201– 201, 1983. 17 Bell, D. A. & Maddison, P. J.: An examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritisn examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritisns. Arthritiss. Arthritis. Arthritisrthritis Rheum. 23, 1268– 1273, 1980. 18 Bendixen, G., Hadidi, T., Manthorpe, R., et al.: Antibodies against nuclear components in schistosomiasis. Allergy 39, 107– 112, 1984. 19 Bernstein, R. M., Morgan, S. H., Chapman, J., et al.: Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br. Med. J. 289, 151– 152, 1984. 20 Bernstein, R. M., Bunn, C. C. & Mathews, M. B.: Autoantibodies to transfer RNA-related antigens in myositis. In H. Peeters, (ed.): Protides of the biological fluids, pp. 327– 350. Pergamon Press, Oxford , 1985. 21 Bernstein, R. M., Bunn, C. C., Hughes, G. R. V., Francoeur, A. M. & Mathews, M. B.: Cellular protein and RNA antigens in autoimmune disease. Mol. Biol. Med. 2, 105– 120, 1984. 22 Bernstein, R. M. & Hobbs, R. N.: Antibodies to histones: different patterns of response in idiopathic SLE and drug-induced lupus. In H. Peeters, (ed.): Protides of the biological fluids, pp. 321– 323. Pergamon Press, Oxford , 1985. 23 Bernstein, R. M., Hobbs, R. N., Lea, D. J., Ward, D. J. & Hughes, G. R. V.: Patterns of antihistone antibody specificity in systemic rheumatic diseases. I. Systemic lupus erythematosus, mixed connective tissue disease, primary sicca syndrome, and rheumatoid arthritis with vasculitis. Arthritis Rheum. 28, 285– 293, 1985. 24 Bernstein, R. M., Steigerwald, J. C. & Tan, E. M.: Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin. Exp. Immunol. 48, 43– 51, 1982. 25 Billings, P. B., Hoch, S. O., White, P. J., Carson, D. A. & Vaughan, J. H.: Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide. Proc. Natl. Acad. Sci. USA 80, 7104– 7108, 1983. 26 Brenner, S., Pepper, D., Berns, M. W., Tan, E. M. & Brinkley, B. R.: Kinetochore structure duplication and distribution in mammalian cells: analysis by human autoantibodies from scleroderma patients. J. Cell. Biol. 91, 95– 100, 1981. 27 Buchanan, R. R. C., Venables, P. J. W., Morgan, A., Staines, N. A., Smith, P. R. & Maini, R. N.: Separation of two molecular species of the Sm antigen by affinity chromatography with murine monoclonal and human anti-nuclear autoantibodies. Clin. Exp. Immunol. 51, 8– 16, 1983. 28 Bunn, C. C., Gharavi, A. E. & Hughes, G. R. V.: Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigens observed by counterelectrophoresis. J. Clin. Lab. Immunol. 8, 13– 17, 1982. 29 Carson, D. A., Lawrance, S., Slaughter, L. & Vaughan, J. H.: Immunochemical properties of anti-IgG antibodies. In G. S. Panayi & P. M. Johnson, (eds.): Immunopathogenesis of rheumatoid arthritis, pp. 51– 55. Reedbooks, Surrey , 1979. 30 Catalano, M. A., Carson, D. A., Niederman, J. C., Feorino, P. & Vaughan, J. H.: Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr infection. J. Clin. Invest. 65, 1238– 1242, 1980. 31 Catalano, M. A., Carson, D. A., Slovin, S. F. Richman, D. D. & Vaughan, J. H.: Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 76, 5825– 5828, 1979. 32 Catoggio, L. J., Bernstein, R. M., Black, C. M., Hughes, G. R. V. & Maddison, P. J.: Serological markers in progressive systemic sclerosis: clinical correlations. Ann. Rheum. Dis. 42, 23– 27, 1983. 33 Celis, J. E., Bravo, R., Mose Larsen, P. & Fey, S. J.: Cyclin a nuclear protein whose level correlates directly with the proliferative state of normal as well as trans formed cells. Leuk.yclin a nuclear protein whose level correlates directly with the proliferative state of normal as well as trans formed cells. Leuk.ls. Leuk.s. Leuk.. Leuk.euk. Res. 8, 143– 157, 1984. 34 Chapman, J R., Charles, P. J., Venables, P. J. W., Maini, R. N. & Turner-Warwick, M.: Definition and clinical relevance of antibodies to n-ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosis, alveolitis. Am. Rev. Respir. Dis. 130, 439– 443, 1984. 35 Clark, G., Reichlin, M. & Tomasi, T. B.: Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J. Immunol. 102, 117– 122, 1969. 36 Cohen, J. H. M. & Lenoir, G. M.: Epstein-Barr virus and rheumatoid arthritis: are rheumatoid associated nuclear antigen and Epstein-Barr virus nuclear antigen different. Biomed. Pharmacother. 36, 246– 249, 1982. 37 Colaco, C. B. & Elkon, K. B.: The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double stranded DNA. Arthritis Rheum. 28, 67– 74, 1985. 38 Dang, H. & Harbeck, R. J.: The in vivo and in vitro glomerular deposition of isolated anti-double stranded DNA antibodies in NZB/W mice. Clin. Immunol. Immunopathol. 30, 265– 278, 1984. 39 De Carvalho, A. & Graudal, H.: Radiographic progression of rheumatoid arthritis related to some clinical and laboratory parameters. Acta Radiol. Diagnosis 21, 551– 555, 1980. 40 Deng, J. S., Sontheimer, R. D., Lipscomb, M. F. & Gilliam, J. N.: The binding of antihistone antibodies to Crithidia luciliae kinetoplasts is growth cycle-dependent. Arthritishe binding of antihistone antibodies to Crithidia luciliae kinetoplasts is growth cycle-dependent. Arthritisnt. Arthritist. Arthritis. Arthritisrthritis Rheum. 28, 163– 167, 1985. 41 Douvas, A. S., Achten, M. & Tan, E. M.: Identification of a nuclear protein (Scl-70) as unique target of human antinuclear antibodies in scleroderma. J. Biol. Chem. 254, 10514– 10522, 1979. 42 Dubois, E. L.: Current status of the LE cell test. Semin. Arthritis Rheum. 1, 97– 123, 1971. 43 Earnshaw, W., Bordwell, B., Marino, C. & Rothfield, N.: Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies. J. Clin. Invest. 77, 426– 430, 1986. 44 Eilat, D.: Cross-reactions of anti-DNA antibodies and the central dogma of lupus nephritis. Immunologyross-reactions of anti-DNA antibodies and the central dogma of lupus nephritis. Immunologyis. Immunologys. Immunology. Immunologymmunology Today 6, 123– 127, 1985. 45 Elkon, K. B. & Jankowski, P. W.: Fine specificities of autoantibodies directed against the Ro, La, Sm, RNP and Jo-1 proteins defined by two-dimensional gel electrophoresis and immunoblotting. J. Immunol. 134, 3819– 3824, 1985. 46 Epstein, A. & Barland, P.: The diagnostic value of anti-histone antibodies in drug-induced lupus erythematosus. Arthritishe diagnostic value of anti-histone antibodies in drug-induced lupus erythematosus. Arthritisus. Arthritiss. Arthritis. Arthritisrthritis Rheum. 28, 158– 162, 1985. 47 Faaber, P., Capel, P. J. A., Rijke, G. P. M., Vierwinden, G., van der Putte, L. B. A. & Koene, R. A. P.: Cross-reactivity of anti-DNA antibodies with proteoglycans. Clin. Exp. Immunol. 55, 502– 508, 1984. 48 Faber, V., Elling, P., Norup, G., Mansa, B. & Nissen, N. I.: An antinuclear factor specific for leucocytes. Lancet ii, 344– 345, 1964. 49 Fernandez-Madrid, F. & Mattioli, M.: Antinuclear antibodies (ANA): immunologic and clinical significance. Semin.ntinuclear antibodies (ANA): immunologic and clinical significance. Semin.ce. Semin.e. Semin.. Semin.emin. Arthritis Rheum. 6, 83– 124, 1976. 50 Forstot, J., Forstot, S. L., Greer, R. O. & Tan, E. M.: The incidence of Sjøgren's sicca complex in a population of patients with keratoconjunctivitis sicca. Arthritishe incidence of Sjøgren's sicca complex in a population of patients with keratoconjunctivitis sicca. Arthritisca. Arthritisa. Arthritis. Arthritisrthritis Rheum. 25, 156– 160, 1982. 51 Fox, R., Sportsman, R., Rhodes, G., Luka, J., Pear son, G. & Vaughan, J.: Rheumatoid arthritis synovial membrane contains a 62,000 molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen. J. Clin. Invest. 77, 1539– 1547, 1986. 52 Francoeur, A.-M., Gritzmacer, C. A., Peebles, C. L., Reese, R. T. & Tan, E. M.: Synthesis of small nuclear ribonucleoprotein particles by the malarial parasite Plasmodium falciparum. Proc. Nat]. Acad. Sci., USA 82, 3635– 3639, 1985. 53 Francoeur, A.-M. Peebles, C. L., Gompper, P. T. & Tan, E. M.: Identification of Ki (Ku, p7O/p8O) auto antigens and analysis of anti-Ki autoantibody reactivity. J. Immunol. 136, 1648– 1653, 1986. 54 Friou, G. J., Finch, S. C. & Detre, K. D.: Interaction of nuclei and globulin from lupus erythematosus serum demonstrated with fluorescent antibody. J. Immunol. 80, 324– 329, 1958. 55 Fritzler, M. J., Ali, R. & Tan, F. M.: Antibodies from patients with mixed connective tissue disease react with heterogenous nuclear ribonucleoprotein or ribonucleic acid (hnRNP/RNA) of nuclear matrix. J. Immunol 132, 1216– 1222, 1984. 56 Fritzler, M. J. & Tan, E. M.: Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J Clin. Invest. 62, 560– 567, 1978. 57 Fritzler, M. J., Kinsella, T. D. & Garbutt, E.: The CREST syndrome - a distinct entity with anti-centromere antibodies. Am. J. Med. 69, 520– 526, 1980. 58 Geisler, C. & Høier-Madsen, M.: Enzyme immuno assay for the detection of autoantibodies against the nuclear protein Sci 70. In H. Peeters, (ed.) Protides of the biological fluids, pp. 429– 436. Pergamon Press, Oxford , 1985. 59 Geisler, C. & Høier-Madsen, M.: An enzyme-linked immunosorbent assay for autoantibodies against the nuclear protein Scl-70. J. Immunol. Methods. 80, 211– 219, 1985. 60 Gottesfield, J. M., Andrews, D. L. & Hoch, S. O.: Association of an RNA polymerase III transcription factor with a ribonucleoprotein complex recognized by autoimmune sera. Nucl.ssociation of an RNA polymerase III transcription factor with a ribonucleoprotein complex recognized by autoimmune sera. Nucl.ra. Nucl.a. Nucl.. Nucl.ucl. Acids Res. 12, 3185– 3200, 1984. 61 Guldner, H. H., Lakomek, H-J., Szostecki, C. & Bautz, F. A.: Autoantibody profiles in patients with SLE, scleroderma and overlap syndromes. Scand. J. Immunol. Suppl. 56, 287– 291, 1985. 62 Habets, W. J., Berden, J. H. M., Hock, S. O. & van Venrooij, W. J.: Further characterization and sub-cellular localization of Sm and U1 ribonucleoprotein antigens. Eur. J. Immunol. 15, 992– 997, 1985. 63 Habets, W. J., De Rooij, D. J., Hoet, M. H., van der Putte, L. B. & van Venrooij, W. J.: Quantitation of anti-RNP and anti-SM antibodies in MCTD and SLE patients by immunoblotting. Clin. Exp. Immunol. 59, 457– 466, 1985. 64 Habets, W. J., Hoct, M. H., van de Pas, T. & van Venrooij, W. J.: Characterization of nuclear and cytoplasmic autoimmune antigens. In H. Peeters, (ed.): Protides of the biological fluids, pp. 199– 204. Pergamon Press, Oxford , 1985. 65 Hahon, N., Eckert, H. L. & Stewart, J.: Evaluation of cellular substrates for antinuclear antibody determinations. J. Clin. Microbiol. 2, 42– 45, 1975. 66 Hargraves, M. M., Richmond, H. & Morton, R.: Presentation of two bone marrow elements: the tart cell and the LE cell. Proc. Mayo. Clin. 23, 25– 28, 1948. 67 Harley, J. B., Alexander, E. L., Bias, W. B., et al.: Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjøgren's syndrome. Arthritis Rheum. 29, 196– 206, 1986. 68 Harley, J. B., Kaine, J. L., Fox, O. F., Reichlin, M. & Gruber, B.: Ro (SS-A) antibody and antigen in a patient with congenital heart block. Arthritiso (SS-A) antibody and antigen in a patient with congenital heart block. Arthritisck. Arthritisk. Arthritis. Arthritisrthritis Rheum. 28, 1321– 1324, 1985. 69 Harmon, C. E.: Antinuclear antibodies in autoimmune disease. Significance and pathogenicity. Med. Clin. N. Am. 69, 547– 563, 1985. 70 Harmon, C., Peebles, C. & Tan, E. M.: SL-a new precipitating system. Arthritis Rheum. 24, s. 122 (Abstract), 1981. 71 Hoch, S.: Autoimmune antigens and viral infection. Scand. J. Rheumatol. Suppl. 56, 58– 64, 1985. 72 Holborow, E. J., Wyier, D. M. & Johanson, G. D.: Aserum factor in lupus erythematosus with affinity for tissue nuclei. Br. Med. J. ii, 732– 738, 1957. 73 Holman, H. & Deicher, H. R.: The reaction of the lupus erythematosus (LE) cell factor with deoxyribonucleoprotein of the cell nucleus. J. Clin. Invest. 38, 2059– 2072, 1959. 74 Holman, H. R.: Partial purification and characterization of an extractable nuclear antigen which reacts with SLE sera. Ann. N. Y. Acad. Sci. 124, 800– 806, 1965. 75 Houtman, P. M., Kallenberg, C. G. M., Limburg, P. C., van Rijswijk, M. H. & The, T. H.: Are anti- nRNP levels specific guides for assessing disease activity in patients with (mixed) connective tissue disease. In H. Peeters, (ed.): Protides of the biological fluids, pp. 357– 358. Pergamon Press, Oxford , 1985. 76 Humbel, R. & Kadusch, P.: Use of HEp-2-cells in the IF test for detection of antinuclear antibodies. In H. Peeters, (ed.): Protides of the biological fluids, pp. 385– 387. Pergamon Press, Oxford , 1985. 77 Jacob, L., Tron, F., Bach, J. F. & Louvard, D.: A monoclonal anti-DNA antibody also binds to cell-surface protein (s). Proc. Natl. Acad. Sci. USA. 81, 3843– 3845, 1984. 78 Koffler, D., Schur, P. H. & Kunkel, H. G.: Immunological studies concerning the nephritis of systemic lupus erythematosus. J. Exp. Med. 26, 607– 623, 1967. 79 Koffler, D., Agnello, V. & Kunkel, H. G.: Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus. Am. J. Pathol. 74, 109– 124, 1974. 80 Koike, T., Tomioka, H. & Kumagai, A.: Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 50, 298– 302, 1982. 81 Kunkel, H. G., Holman, H. R. & Deicher, H. R. G.: Multiple autoantibodies to cell constituents in systemic lupus erythematosus, pp. 429– 437. Ciba Foundation Symposium. Basel , 1960. 82 Kurilla, M. G. & Keene, J. D.: The leader RNA of vesicular stomatitis virus is bound by a cellular protein reactive with anti-La lupus antibodies. Cell 34, 837– 845, 1983. 83 Lake, R. A., Morgan, A., Henderson, B. & Staines, N. A.: A key role for fibronectin in the sequential binding of native dsDNA and monoclonal anti–DNA antibodies to components of the extracellular matrix: its possible significance in glomerulonephritis. Immunology 54, 389– 395, 1985. 84 Lamon, E. W. & Bennett, J. C.: Antibodies to ribosomal ribonucleic acid (rRNA) in patients with systemic lupus erythematosus. Immunology 19, 439– 442, 1970. 85 Lerner, E. A., Lerner, M. R., Hardin, J. A., Jane-way, C. A. Jr. & Steitz, J. A.: Deciphering the mysteries of RNA-containing lupus antigens. Arthritis Rheum. 25, 761– 766, 1982. 86 Lerner, M. R., Boule, J. A., Hardin, J. A. & Steitz, J. A.: Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. Science 211, 400– 402, 1981. 87 Lerner, M. R., Boyle, J. A., Mount, S. M., Wolin, S. L. & Steitz, J. A.: Are sn RNPs involved in splicing. Nature 283, 220– 224, 1980. 88 Lerner, M. R. & Steitz, J. A.: Antibodies to small nuclear RNA's complexed with proteins are produced by patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 76, 5495– 5499, 1979. 89 Lerner, M. R., Andrews, N. C., Miller, G. & Steitz, J. A.: Two small RNA's encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 78, 805– 809, 1981. 90 Lischwe, M. A., Ochs, R. L., Reddy, R., et al.: Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000, pI, 8,5) rich in N G, N G-dimethylarginine. J. Biol. Chem. 260, 14304– 12310, 1985. 91 Maddison, P., Mogavero, H., Provost, T. T. & Reichlin, M.: The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases. J. Rheumatol. 6, 198– 195, 1979. 92 Maddison, P. J., Provost, T. T. & Reichlin, M.: Serological findings in patients with “ANA negative” systemic lupus erythematosus. Medicine 60, 87– 94, 1981. 93 Maddison, P. J. & Reichlin, M.: Quantitation of precipitating antibodies to certain soluble nuclear anti gens in SLE. Their contribution to hypergam maglobulinemia. Arthritis Rheum. 20, 819– 824, 1977. 94 Maddison, P. N. & Rechlin, M.: Deposition of anti bodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus. Arthritiseposition of anti bodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus. Arthritisus. Arthritiss. Arthritis. Arthritisrthritis Rheum. 22, 858– 863, 1979. 95 Maini, R. N., Charles, P. J. & Venables, P. J. W.: Antinuclear antibodies in the immunotaxonomy of connective tissue diseases. Scand. J. Rheumatol. Suppl. 56, 49– 57, 1985. 96 Martinez-Lavin, M., Vaughan, J. H. & Tan, E. M.: Autoantibodies and the spectrum of Sjøgren's syndrome. Ann. Intern. Med. 91, 185– 190, 1979. 97 Mathews, M. B., Bernstein, R. M., Eranza, B. R. Jr. & Garels, J. I.: The identity of the “proliferating cell nuclear antigen” and “cyclin”. Nature 309, 374– 376, 1984. 98 Mathews, M. B., Hughes, G. R. V. & Bernstein, R. M.: Antithreonyl-tRNA synthetase, a second myositis - related autoantibody. J. Exp. Med. 160, 420– 434, 1984. 99 Mathews, M. B., & Bernstein, R. M.: Myositis auto antibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 304, 177– 179, 1983. 100 Matter, L., Schopfer, J. A., Wilhelm, J. A., Nyfenegger, T., Parisot, R. E. & De Robertis, E. M.: Molecular characterization of ribonucleoprotein antigens bound by antinuclear antibodies. A diagnostic evaluation. Arthritis Rheum. 25, 1278– 1283, 1982. 101 Mattioli, M. & Reichlin, M.: Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera. J. Immunol. 107, 1281– 1290, 1971. 102 Mattioli, M. & Reichlin, M.: Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic non-ribosomal antigen. Arthritis Rheum. 17, 421– 429, 1974. 103 Mattioli, M. & Reichlin, M.: Physical association of two nuclear antigens and mutual occurrence of their antibodies: the relationship of the Sm and RNA protein (Mo) systems in SLE sera. J. Immunol. 11, 1318– 1324, 1973. 104 McCarthy, G. A., Valencia, D. W. & Eritzler, M. J.: Antibody to the mitotic spindle apparatus: immunologic characteristics and cytologic studies. J. Rheumatol. 11, 213– 218, 1984. 105 McCarthy, G. A., Rice, J. R., Bembe, M. L. & Barada, E. A. Jr.: Anti-centromere antibody. Clinical correlations and association with favourable prognosis in patients with scleroderma variants. Arthritis Rheum. 26, 1– 7, 1983. 106 McGhee, J. D. & Felsenfeld, G.: Nucleosome structure. Ann. Rev. Biochem. 49, 1115– 1156, 1980. 107 McKean, E. D., Tuffanelli, D. L., Fukuyama, K. & Kirschner, M. W.: Autoimmune response directed against conserved determinants of nuclear envelope proteins in a patient with linear scleroderma. Proc. Natl. Acad. Sci., USA 80, 4374– 4378, 1983. 108 Meyer, O., Legmann, E., Haim, T. & Ryckewaert, A.: Diversity of antinuclear antibodies in 42 cases of polydermatomyositis (PM/DM). In H. Peeters, (ed.): Protides of the biological fluids, pp. 351– 355. Pergamon Press, Oxford 1985. 109 Miamori, T., Akuzuki, M., Yamagata, H., Inada, S., Yoshida, S. & Homma, M.: Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis scleroderma overlap. J. Clin. Invest. 68m 511– 620, 1981. 110 Mimori, T., Hardin, J. A. & Steitz, J. A.: Characterization of the DNA-binding protein Ku recognized by autoantibodies from patients with rheumatic disorders. J. Biol. Chem. 261, 2274– 2278, 1986. 111 Miyachi, K., Fritzler, M. J. & Tan, E. M.: Autoantibodies to a nuclear antigen in proliferating cells. J. Immunol. 121, 2228– 2234, 1978. 112 Molinar, R., Provost, T. T. & Alexander, E.: Two types of inflammatory vascular disease in Sjøgren's syndrome. Differential association with seroreactivity to rheumatoid factor and antibodies to Ro (SS-A) and with hypocomplementemia. Arthritis Rheum. 28, 1251– 1258, 1985. 113 Moroi, Y., Peebles, C., Fritzler, M. J., Steigerwald, J. & Tan, E. M.: Autoantibody to centromere (kinetochore) in scleroderma sera. Proc. Natl. Acad, Sci. USA 77, 1627– 1331, 1980. 114 Moroi, Y., Hartman, A. L., Nakaae, P. K. & Tan, E. M.: Distribution of kinetochore (centromere) antigen in mammalian cell nuclei. J. Cell. Biol. 90, 254– 295, 1981. 115 Morris, A. D., Littleton, C., Corman, L. C., Esterly, J. & Sharp, G. C.: Extractable nuclear antigen effect on the DNA-anti-DNA reaction and NZB/NZW mouse nephritis. J. Clin. Invest. 55, 903– 907, 1975. 116 Moutsopoulos, H. M., Klippel, J. H., Pavlidis, N., et al.: Correlative histologic and serologic findings of sicca syndrome in patients with systemic lupus erythematosus. Arthritisorrelative histologic and serologic findings of sicca syndrome in patients with systemic lupus erythematosus. Arthritisus. Arthritiss. Arthritis. Arthritisrthritis Rheum. 23, 36– 40, 1980. 117 Moutsopoulos, H. M., Skopouli, E. N., Sarras, A. K., et al.: Anti-Ro (SS-A) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects. Ann. Rheum. Dis. 44, 215– 219, 1985. 118 Munves, E. F. & Schur, P. H.: Antibodies to Sm and RNP. Prognosticators of disease involvement. Arthritis Rheum 26, 848– 853, 1983. 119 Nakamura, R. M. & Tan, E. M.: Recent progress in the study of autoantibodies to nuclear antigens. Hum.ecent progress in the study of autoantibodies to nuclear antigens. Hum.ns. Hum.s. Hum.. Hum.um. Pathol. 9, 85–" @default.
• W1486098081 created "2016-06-24" @default.
• W1486098081 creator A5020989900 @default.
• W1486098081 date "1987-05-01" @default.
• W1486098081 modified "2023-09-27" @default.
• W1486098081 title "The value of specific ANA determination in rheumatology." @default.
• W1486098081 cites W1520268659 @default.
• W1486098081 cites W1528262319 @default.
• W1486098081 cites W1551566234 @default.
• W1486098081 cites W1560448233 @default.
• W1486098081 cites W1578653585 @default.
• W1486098081 cites W1594164646 @default.
• W1486098081 cites W160997634 @default.
• W1486098081 cites W1822675032 @default.
• W1486098081 cites W1963945655 @default.
• W1486098081 cites W1964046473 @default.
• W1486098081 cites W1966519293 @default.
• W1486098081 cites W1967183938 @default.
• W1486098081 cites W1967937304 @default.
• W1486098081 cites W1972326289 @default.
• W1486098081 cites W1976732266 @default.
• W1486098081 cites W1977209683 @default.
• W1486098081 cites W1977761564 @default.
• W1486098081 cites W1982610079 @default.
• W1486098081 cites W1983099688 @default.
• W1486098081 cites W1986347272 @default.
• W1486098081 cites W1987238364 @default.
• W1486098081 cites W1988686596 @default.
• W1486098081 cites W1991332388 @default.
• W1486098081 cites W1992209996 @default.
• W1486098081 cites W1993242309 @default.
• W1486098081 cites W1994719559 @default.
• W1486098081 cites W1994748744 @default.
• W1486098081 cites W1996631006 @default.
• W1486098081 cites W1997661722 @default.
• W1486098081 cites W1999227659 @default.
• W1486098081 cites W2000301518 @default.
• W1486098081 cites W2002027999 @default.
• W1486098081 cites W2002205128 @default.
• W1486098081 cites W2002400744 @default.
• W1486098081 cites W2008485536 @default.
• W1486098081 cites W2010100867 @default.
• W1486098081 cites W2010664601 @default.
• W1486098081 cites W2012284676 @default.
• W1486098081 cites W2012552244 @default.
• W1486098081 cites W2012904701 @default.
• W1486098081 cites W2015265853 @default.
• W1486098081 cites W2015438650 @default.
• W1486098081 cites W2018967405 @default.
• W1486098081 cites W2019383556 @default.
• W1486098081 cites W2020927386 @default.
• W1486098081 cites W2021073642 @default.
• W1486098081 cites W2021783076 @default.
• W1486098081 cites W2024848135 @default.
• W1486098081 cites W2025973568 @default.
• W1486098081 cites W2027063893 @default.
• W1486098081 cites W2027335024 @default.
• W1486098081 cites W2027354239 @default.
• W1486098081 cites W2028009985 @default.
• W1486098081 cites W2028686719 @default.
• W1486098081 cites W2028815663 @default.
• W1486098081 cites W2030070609 @default.
• W1486098081 cites W2031481693 @default.
• W1486098081 cites W2031642976 @default.
• W1486098081 cites W2034490386 @default.
• W1486098081 cites W2034560174 @default.
• W1486098081 cites W2035449296 @default.
• W1486098081 cites W2039524691 @default.
• W1486098081 cites W2040776780 @default.
• W1486098081 cites W2041774332 @default.
• W1486098081 cites W2043824741 @default.
• W1486098081 cites W2044907680 @default.
• W1486098081 cites W2047382786 @default.
• W1486098081 cites W2048428291 @default.
• W1486098081 cites W2048761166 @default.
• W1486098081 cites W2049857396 @default.
• W1486098081 cites W2053545152 @default.
• W1486098081 cites W2054730986 @default.
• W1486098081 cites W2062531827 @default.
• W1486098081 cites W2065054003 @default.
• W1486098081 cites W2065844116 @default.
• W1486098081 cites W2067829451 @default.
• W1486098081 cites W2068835891 @default.
• W1486098081 cites W2073898388 @default.
• W1486098081 cites W2074281427 @default.
• W1486098081 cites W2076718946 @default.
• W1486098081 cites W2077248019 @default.
• W1486098081 cites W2077417728 @default.
• W1486098081 cites W2081761746 @default.
• W1486098081 cites W2082995756 @default.
• W1486098081 cites W2083416114 @default.
• W1486098081 cites W2087400511 @default.
• W1486098081 cites W2087833598 @default.
• W1486098081 cites W2087989707 @default.
• W1486098081 cites W2090041541 @default.
• W1486098081 cites W2090044525 @default.
• W1486098081 cites W2090445428 @default.
• W1486098081 cites W2090694551 @default.

• next